Scheme 1From: Nanoarchitectured conjugates targeting angiogenesis: investigating heparin-taurocholate acid conjugates (LHT7) as an advanced anti-angiogenic therapy for brain tumor treatmentA comprehensive illustration of LHT7 synthesis and its mechanism of action in anti-angiogenic glioblastoma therapyBack to article page